- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2016
- Public Summary Document (PSD) November 2016 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2016 PBAC Meeting - Word
Sofosbuvir with velpatasvir – November 2016
Sofosbuvir with velpatasvir: Tablet containing 400 mg sofosbuvir with 100 mg velpatasvir; Epclusa®
Last updated
3 March 2017